With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Mechanisms and Targeted Inhibition of NT5C2 Mutations in Relapsed ALL||Columbia University / Adolfo A. Ferrando, M.D., Ph.D.||Innovation Grants||2014||New York|
|Autophagy and mTOR Inhibition in Pediatric Gliomas with BRAF Mutations||University of Colorado Denver / Jean Mulcahy Levy, MD||Young Investigator Grants||2014||Colorado|
|Investigation of Oncogenic Long Non-coding RNAs in Ewing sarcoma||Lucile Packard Children's Hospital at Stanford University School of Medicine / Siu Ping Ngok, PhD||Young Investigator Grants||2014||California|
|Translating BET Bromodomain Inhibitors for Acute Myeloid Leukemia Therapy||Dana-Farber Cancer Institute / Yana Pikman, MD||Young Investigator Grants||2014||Massachusetts|
|Targeted Therapy for Core Binding Factor Leukemia||University of Massachusetts Medical School / John Pulikkan, PhD||Young Investigator Grants||2014||Massachusetts|
|Deciphering the Mechanisms of Medulloblastoma Treatment Resistance using Integrative Genomics||Hospital for Sick Children / Vijay Ramaswamy, MD||Young Investigator Grants||2014||Ontario|
|Understanding and Preventing Healthy Tissue Damage in Pediatric Cancer Patients||Dana-Farber Cancer Institute / Kristopher Sarosiek, PhD||Young Investigator Grants||2014||Massachusetts|
|Targeting the Epigenome of Diffuse Intrinsic Pontine Glioma||The Johns Hopkins University School of Medicine / Sama Ahsan, MD||Young Investigator Grants||2014||Maryland|
|Targeting Aberrant Hh Signaling with BET Bromodomain Inhibition as a Novel Therapeutic Strategy Against MB and DIPG||Lucile Packard Children's Hospital at Stanford University School of Medicine / Yujie Tang, PhD||Young Investigator Grants||2014||California|
|Targeting the Thymic Stromal Lymphopoeitin Receptor Signaling Axis to Reduce Relapse of High Risk Pediatric Acute Lymphoblastic Leukemia||National Cancer Institute / Christopher Chien, PhD||Young Investigator Grants||2014||Maryland|